GlassScriptPhysician profile
Lori A Dickson
NPI 1770781056
$1,526.28
in general payments reported to CMS, 2019-2025
15 companies · $16.49 in 2025
The $16.49 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $299 · 2023: $772 · 2024: $438 · 2025: $16.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $450.16 | 2022-2024 | |
| Lundbeck LLC | $136.39 | 2022-2024 | Rexulti |
| Neurocrine Biosciences, INC. | $123.19 | 2022-2024 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $121.81 | 2023-2024 | Caplyta |
| Axsome Therapeutics, INC. | $115.95 | 2022-2023 | Auvelity, Sunosi |
| Supernus Pharmaceuticals, INC. | $104.08 | 2023-2024 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $102.90 | 2022-2024 | Rexulti, Abilify Maintena |
| Takeda Pharmaceuticals U.S.A., INC. | $80.18 | 2022-2024 | Trintellix |
| Idorsia Pharmaceuticals US INC | $79.63 | 2022-2024 | Quviviq |
| Alkermes, INC. | $74.37 | 2023-2024 | Lybalvi, Aristada |
| Bausch Health US, LLC | $38.62 | 2022-2023 | Aplenzin |
| Noven Therapeutics, LLC | $37.04 | 2024 | Xelstrym, Secuado |
| Vanda Pharmaceuticals INC. | $30.61 | 2022 | |
| Siemens Medical Solutions USA, INC. | $16.49 | 2025 | Artis Icono Biplane |
| Janssen Pharmaceuticals, INC | $14.86 | 2024 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Dickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.